[1] Rota P A, Oberste M S, Monroe S S, et al. Characterization of a novel coronavirus associated with severe acute respiratory syndrome[J]. Science, 2003, 300(5624):1394-1399.
[2] 陈冯富珍. 全球卫生观察站数据[EB/OL].[2016-05-27].http://www.who.int/gho/zh/.
[3] Zaki A M, van Boheemen S, Bestebroer T M, et al. Isolation of a novel coronavirus from a man with pneumonia in Saudi Arabia[J]. N Engl J Med, 2012, 367(19):1814-1820.
[4] 陈冯富珍. 全球卫生观察站数据[EB/OL].[2017-01-05].http://www.who.int/emergencies/mers-cov/en/.
[5] Ren L, Gonzalez R, Xu J, et al. Prevalence of human coronaviruses in adults with acute respiratory tract infections in Beijing, China[J]. J Med Virol, 2011, 83(2):291-297.
[6] Lu R, Yu X, Wang W, et al. Characterization of human coronavirus etiology in Chinese adults with acute upper respiratory tract infection by real-time RT-PCR assays[J]. PLoS One, 2012,7(6):e38638.
[7] Woo P C, Lau S K, Chu C M, et al. Characterization and Complete Genome Sequence of a Novel Coronavirus, Coronavirus HKU1, from Patients with Pneumonia[J]. J Virol,2005, 79(2):884-895.
[8] Matoba Y, Abiko C, Ikeda T, et al. Detection of the human coronavirus 229E, HKU1, NL63, and OC43 between 2010 and 2013 in Yamagata, Japan[J]. Jpn J Infect Dis, 2015, 68(2):138-41.
[9] Dominguez S R, Shrivastava S, Berglund A, et al. Isolation, propagation, genome analysis and epidemiology of HKU1 betacoronaviruses[J]. J Gen Virol, 2014, 95(Pt 4):836-848.
[10] Lee W J, Chung Y S, Yoon H S,et al. Prevalence and molecular epidemiology of human coronavirus HKU1 in patients with acute respiratory illness[J]. J Med Virol, 2013, 85(2):309-314.
[11] Al-Khannaq M N, Ng K T, Oong X Y, et al. Molecular epidemiology and evolutionary histories of human coronavirus OC43 and HKU1 among patients with upper respiratory tract infections in Kuala Lumpur, Malaysia[J]. Virol J, 2016, 13:33.
[12] Sipulwa L A, Ongus J R, Coldren R L, et al. Molecular characterization of human coronaviruses and their circulation dynamics in Kenya, 2009-2012[J]. Virol J, 2016, 13:18.
[13] 段招军, 黄灿平, 瞿小旺, 等. 中国内陆发现HCoV-HKU1感染及N和S蛋白基因序列及进化分析[J].病毒学报, 2006, 22(4):241-247.
[14] Cui L J, Zhang C, Zhang T, et al. Human coronaviruses HCoV-NL63 and HCoV-HKU1 in hospitalized children with acute respiratory infections in Beijing, China[J]. Adv Virol, 2011, 2011:129-134.
[15] Sloots T P, McErlean P, Speicher D J, et al. Evidence of human coronavirus HKU1 and human bocavirus in Australian children[J]. J Clin Virol, 2006, 35(1): 99-102.
[16] Lau S K, Woo P C, Yip C C, et al. Coronavirus HCOV-HKU1 and other coronavirus infections in HongKong[J]. J Clin Microbiol, 2006, 44(6):2063-2071.
[17] Vabret A, Dina J, Gouarin S, et al. Detection of new human coronavirus. HCOV-HKU1: a report of 6 cases[J]. Clin Infect Dis, 2006, 42(5):634-639.
[18] Wu K, Li W, Peng G, et al. Crystal structure of NL63 respiratory coronavirus receptor-binding domain complexed with its human receptor[J]. Proc Natl Acad Sci USA, 2009, 106(47):19970-19974.
[19] Peng G Q, Sun D W, Rajashankar K R, et al. Crystal structure of mouse coronavirus receptor-binding domain complexed with its murine receptor[J]. Proc Natl Acad Sci USA, 2011, 108:10696–10701.
[20] Li F. Receptor recognition and cross-species infections of SARS coronavirus[J]. Antiviral Res, 2013, 100:246–254.
[21] Li F. Receptor Recognition Mechanisms of Coronaviruses: a Decade of Structural Studies[R]. J Virol, 2015, 89(4):1954-1964.
[22] Kirchdoerfer R N, Cottrell C A, Wang N, et al. Pre-fusion structure of a human coronavirus spike protein[J]. Nature, 2016, 531(7592):118-121.
[23] Peng G Q, Xu L Q, Lin Y L, et al. Crystal structure of bovine coronavirus spike protein lectin domain[J]. J Biol Chem, 2012, 287:41931-41938.
[24] Reguera J, Mudgal G, Santiago C, et al. A structural view of coronavirus-receptor interactions[J]. Virus Res, 2014, 194:3-15.
[25] Meng F, Suo S, Zarlenga D S, et al. A phage-displayed peptide recognizing porcine aminopeptidase N is a potent small molecule inhibitor of PEDV entry[J]. Virology, 2014, 456-457:20-27.
[26] Li F, Li W, Farzan M, Harrison S C. Structure of SARS coronavirus spike receptor-binding domain complexed with receptor[J]. Science, 2005,309(5742):1864-1868.
[27] Wang N, Shi X, Jiang L, et al. Structure of MERS-CoV spike receptor-binding domain complexed with human receptor DPP4[J]. Cell Res,2013,23(8):986-993.
[28] Huang X, Dong W, Milewska A, et al. Human Coronavirus HKU1 Spike Protein Uses O-Acetylated Sialic Acid as an Attachment Receptor Determinant and Employs Hemagglutinin-Esterase Protein as a Receptor-Destroying Enzyme[J]. J Virol, 2015, 89(14):7202-13.
[29] Qian Z, Ou X, Góes L G, et al. Identification of the Receptor-Binding Domain of the Spike Glycoprotein of Human Betacoronavirus HKU1[J]. J Virol, 2015, 89(17):8816-8827.
[30] 陶靖隆, 王爱昕, 张 伟, 等. 人冠状病毒HKU1 Spike蛋白受体结合域结构预测[J]. 武警后勤学院学报, 2016, 25(6):421-427.